Determinants of loss to care and risk of clinical progression in PLWH who are re-engaged in care after a temporary loss.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 05 2021
05 05 2021
Historique:
received:
26
06
2020
accepted:
06
04
2021
entrez:
6
5
2021
pubmed:
7
5
2021
medline:
25
2
2023
Statut:
epublish
Résumé
The risk of developing AIDS is elevated not only among those with a late HIV diagnosis but also among those lost to care (LTC). The aims were to address the risk of becoming LTC and of clinical progression in LTC patients who re-enter care. Patients were defined as LTC if they had no visit for ≥ 18 months. Of these, persons with subsequent visits were defined as re-engaged in care (RIC). Factors associated with becoming LTC and RIC were investigated. The risk of disease progression was estimated by comparing RIC with patients continuously followed. Over 11,285 individuals included, 3962 became LTC, and of these, 1062 were RIC. Older age, presentation with AIDS and with higher HIV-RNA were associated with a reduced risk of LTC. In contrast, lower education level, irregular job, being an immigrant and injecting-drug user were associated with an increased LTC probability. Moreover, RIC with HIV-RNA > 200 copies/mL at the re-entry had a higher risk of clinical progression, while those with HIV-RNA ≤ 200 copies/mL had a higher risk of only non-AIDS progression. Patients re-entering care after being LTC appeared to be at higher risk of clinical progression than those continuously in care. Active strategies for re-engagement in care should be promoted.
Identifiants
pubmed: 33953250
doi: 10.1038/s41598-021-88367-5
pii: 10.1038/s41598-021-88367-5
pmc: PMC8099893
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9632Références
Clin Infect Dis. 2017 Jun 15;64(12):1644-1656
pubmed: 28369283
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
AIDS. 2010 Nov 13;24(17):2665-78
pubmed: 20841990
J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):333-9
pubmed: 24129370
Lancet Public Health. 2017 Jan;2(1):e35-e46
pubmed: 29249478
J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):492-8
pubmed: 18989233
Sex Transm Infect. 2013 Nov;89(7):553-6
pubmed: 23698511
Clin Infect Dis. 2009 Jan 15;48(2):248-56
pubmed: 19072715
Clin Infect Dis. 2011 Mar 15;52(6):793-800
pubmed: 21367734
Epidemiology. 2019 Jan;30(1):69-74
pubmed: 30273188
PLoS One. 2018 Mar 15;13(3):e0194228
pubmed: 29543857
PLoS Med. 2016 Nov 29;13(11):e1002183
pubmed: 27898679
HIV Med. 2019 Feb;20(2):88-98
pubmed: 30474908
JAMA. 2018 Jul 24;320(4):379-396
pubmed: 30043070
J Acquir Immune Defic Syndr. 2017 Feb 1;74 Suppl 2:S113-S120
pubmed: 28079721
JAMA. 2018 Mar 20;319(11):1103-1112
pubmed: 29509839
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Ann Intern Med. 2018 Jul 17;169(2):87-96
pubmed: 29893768
J Acquir Immune Defic Syndr. 2009 Dec;52(5):588-94
pubmed: 19950432
HIV Med. 2011 Aug;12(7):449-50
pubmed: 21729231
J Infect Dis. 2009 Jul 1;200(1):79-87
pubmed: 19476437
PLoS One. 2016 Jan 11;11(1):e0146119
pubmed: 26752637
HIV Med. 2008 May;9(5):261-9
pubmed: 18400074
Clin Infect Dis. 2007 Jun 1;44(11):1493-9
pubmed: 17479948